Metformin in Dengue With Obesity

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

June 1, 2023

Study Completion Date

August 1, 2023

Conditions
DengueViral InfectionMetforminAnti-inflammatory AgentsObesityOverweight
Interventions
DRUG

Metformin

"The trial will be conducted in two phases, with a dose escalation of metformin. Metformin dosing will begin at 500mg (children) and 850mg (adults) once daily for 5 days in cohort 1.~Cohort 2 will be received weight-based doses; 5 days of 1000mg (500mg twice daily) for those weighing \<60kg and 5 days of 1500mg (1000mg mane, 500mg nocte) for those weighing ≥60kg"

Trial Locations (1)

Unknown

Hospital for Tropical Diseases, Ho Chi Minh City

All Listed Sponsors
collaborator

Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

OTHER

lead

Oxford University Clinical Research Unit, Vietnam

OTHER

NCT04377451 - Metformin in Dengue With Obesity | Biotech Hunter | Biotech Hunter